期刊文献+

腹膜透析相关性腹膜炎的致病菌及其耐药性分析 被引量:7

Analysis of pathogens and drug resistance of peritoneal dialysis-related peritonitis
原文传递
导出
摘要 目的探讨腹膜透析相关性腹膜炎的致病菌及其耐药性。方法腹膜透析相关性腹膜炎患者84例,对腹膜炎致病菌的耐药性进行检测,随访治疗结果。结果 84例患者发生腹膜透析相关性腹膜炎93例次,细菌培养阳性65例次(69.9%),其中革兰阳性菌40例次,革兰阴性杆菌19例次,真菌6例次。对革兰阳性菌耐药率较高的是青霉素G、苯唑西林和头孢唑啉;革兰阴性菌中耐药率较高的是氨苄西林、头孢他啶和头孢呋辛钠。真菌感染患者预后差。结论腹膜透析相关性腹膜炎的致病菌谱不断变化,应严格把握抗生素的适应证,减少耐药菌株的产生。 Objective To investigate the pathogens and drug resistance of peritoneal dialysisrelated peritonitis. Methods Eighty-four patients occurred peritoneal dialysis-related peritonitis for 93 times. The bacterial culture and drug sensitivity test were performed and therapeutic results were followed up. Results A total of 65 (69.9%) cases was bacterial culture positive, of which Gram- positive bacteria was found in 40 times, Gram-negative bacilli in 19 times and fungi in 6 times. Resistant drugs against Gram-positive bacteria with higher rate were penicillin G, oxacillin, and cefazolin. Resistant drugs against Gram-negative bacteria with a higher rate were ampicillin, ceftazidime and cefuroxime sodium. The patients with fungal infections had poorer prognosis. Conclusion Spectrum of pathogen in peritoneal dialysis-related peritonitis is changeable. To reduce the strans with drug resistance, the indications for antibiotics use should be strictly grasped.
出处 《江苏医药》 CAS 北大核心 2014年第11期1309-1311,共3页 Jiangsu Medical Journal
关键词 腹膜透析 腹膜炎 病原菌 耐药 Peritoneal dialysis Peritonitis ~ Pathogens ~ Drug resistance
  • 相关文献

参考文献5

  • 1高小夏,潘家荣,邹芸,刘华.持续非卧床腹膜透析患者相关性腹膜炎的原因与防治[J].江苏医药,2012,38(18):2158-2160. 被引量:5
  • 2Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update[J]. Perit Dial Int, 2010,30(4) :393-423.
  • 3Fontdn MP, Cambre HD, Rodriguez-Carmona A, et al. Treat- ment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy clinical outcomes and bacterial susceptibility over two decades[J]. Perit Dial Int, 2009,29 (3) : 310-318.
  • 4Salzer W. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them[J]. Perit Dial Int, 2005,25 (4) : 313-319.
  • 5Persy B, Ieven M. Four-year analysis of microbial aetiology and antimicrobial sensitivity patterns of peritoneal-dialysis related peritonitis in a tertiary care facility[J]. Acta Clin Belg, 2013,68 (1) :48-53.

二级参考文献8

  • 1Mactier R.Peritonitis is still the achilles′heel of peritonealdialysis[J].Perit Dial Int,2009,29(3):262-266.
  • 2Troidle L,Gorban-Brennan N,Kliger A,et al.Continuousperitoneal dialysis-associated peritonitis:a review and currentconcepts[J].Semin Dial,2003,16(6):428-437.
  • 3Chow KM,Szeto CC,Leung CB,et al.A risk analysis ofcontinuous ambulatory peritoneal dialysis-related peritonitis[J].Perit Dial Int,2005,25(4):374-379.
  • 4Miguel A,García-Ramón R,Pérez-Contreras J,et al.Comorbidityand mortality in peritoneal dialysis:a comparative study of typel and 2diabetes versus nondiabetic patients.Peritoneal dialysisand diabetes[J].Nephron,2002,90(3):290-296.
  • 5Rocklin MA,Teitelbaum I.Noninfectious causes of cloudyperitoneal dialysate[J].Semin Dial,2001,14(1):37-40.
  • 6Prasad KN,Prasad N,Gupta A,et al.Fungal peritonitisin patients on continuous ambulatory peritoneal dialysis:asingle centre Indian experience[J].J Infect,2004,48(1):96-101.
  • 7夏红灯,徐元宏.铜绿假单胞菌耐药性及β-内酰胺酶检测与分析[J].安徽医科大学学报,2008,43(5):548-551. 被引量:6
  • 8钱敏,张苗,孙琤,蒋春明,蔡淑琴,童薇.腹膜透析的双联系统对腹膜炎发生率影响的研究[J].江苏医药,2002,28(10):778-779. 被引量:3

共引文献4

同被引文献63

  • 1刘新民,吴扬,宋国培.腹腔穿刺放液灌洗及注射抗生素对肝硬化自发性细菌性腹膜炎的治疗价值[J].现代消化及介入诊疗,2001,6(2):17-19. 被引量:2
  • 2陈明洁,方倜,柯涛,熊志勇,何光源.多重PCR—一种高效快速的分子生物学技术[J].武汉理工大学学报,2005,27(10):33-36. 被引量:72
  • 3l.i I'K, Szeto CC, Piraino B, et al. Peritoneal dialysis-related inft'ctions recommendations: 2010 updateI-J~. Petit Dial Int, 201 O, 30(,1 ) : 393-423.
  • 4Barraclough K, Hawley CM, McDonald SP, et al. Polymicro- bial peritonitis in peritoneal dialysis patients in Australia~ predictors,treatment, and outeomes EJ]. Am J Kidney Dis, 2010,55(1) : 121-131.
  • 5Ho LC,Wang HH,Chiang CK, et al. Malnutrition-inflamma- tion score independently determined cardiovascular and infec- tion risk in peritoneal dialysis patients[J~. Blood Purif, 2010, 29(3) :308-316.
  • 6Niskanen LK, Laaksonen DE, NyyssOnen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study[J]. Areh Intern Med, 2004,164(14) : 1546-1551.
  • 7Latif W, Karaboyas A, Tong L, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population[-J]. Clin J Am Soc Nephrol, 2011, 6 (10) : 2470- 2477.
  • 8Jesfis S, P6rez I,Cdceres-Redondo MT, et al. Low serum uric acid concentration in Parkinson's disease in southern Spain [J]. Eur J Neurol, 2013,20 (1) .- 208-210.
  • 9Badve SV, Hawley CM, McDonald SP, et al. Use of aminogly- cosides for peritoneal dialysis-associated peritonitis does not affect residual renal function[J]. Nephrol Dial Transplant, 2012,27(1) :381-387.
  • 10Oygar DD, Ahiparmak MR, Murtezaoglu A, et al. Fungal peritonitis in peritoneal dialysis: risk factors and prognosis [J]. Ren Fail,2009,31(1) :25-28.

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部